behavior/neurological
• one week following surgery to produce cortical controlled impact (CCI) brain injury, 6-9 week-old null mice show significantly less severe memory deficits than brain-injured wild-type controls based on performance scores in the Morris water maze
|
• at 48 hours after CCI, both injured mutants and controls show significant motor deficits (neuroscores), but those in mutants are less severe than in injured wild-type mice
• at 1 week post-injury, mutants and wild-type mice with CCI display similar neuroscores, and by 3 weeks, wild-type mice show recovery of motor function to wild-type levels whereas Tnf-null injured mice do not display any significant recovery with time
|
• brain-injured Tnf-null mice perform better than injured wild-type in balance beam and rotarod tests at 48 hours post-injury; by 3 weeks, wild-type mice show significant recovery to uninjured control levels while injured mutants display little recovery of function
|
nervous system
• by 1 week post-injury, brain-injured wild-type and Tnf-null mice display a well-developed cavity in ipsilateral cortex; at 4 weeks, in injured wild-type mice, cavity does not extend beyond cortex, but in mutants, cavity reaches white matter or may even become confluent with ventricle
• at 1 week, cavity volume is comparable between wild-type and null mice, but by 2 weeks post-injury, mutants show a greater cortical injury cavity volume than wild-type
|
cellular
• after bleomycin injection, fewer apoptotic inflammatory cells are seen in brochoalveolar lavage fluid (BALF) from Tnf-null lungs compared to wild-type BALF
|
immune system
• intratracheal injection of bleomycin induces infiltration of inflammatory cells in lungs; infiltration reaches peak at day 7 and decreases from that time point in wild-type, but treated mutants show persistent infiltration beyond day 7 to at least day 35 after injection
|
respiratory system
• intratracheal injection of bleomycin induces infiltration of inflammatory cells in lungs; infiltration reaches peak at day 7 and decreases from that time point in wild-type, but treated mutants show persistent infiltration beyond day 7 to at least day 35 after injection
|
• Tnf-null lungs show significantly higher total cell and lymphocyte counts than wild-type at 21 days following intratracheal injection of bleomycin
• inflammatory changes (infiltration by lymphocytes, septal thickening of alveoli, and fibroblast proliferation) subside in wild-type mice by 75 days post-bleomycin treatment but severe infiltration and honeycomb-like structure are still observed in mutant lungs at this time
|